Contact our responsive and friendly client services team any time.
(03) 9028 2888
clients@freshequities.com
▾0.02 (0.02%)
Last trade: Invalid date GMT
-
Recce Pharmaceuticals Ltd (ASX:RCE) is an Australian based globally-focussed, biotechnology company engaged in the development and commercialisation of a new class of antibiotics. RCE's portfolio of antibiotic therapies seek to address health threats posed by drug resistant bacteria. Their lead candidate RECCE®327 is designed as abroad-spectrum antibiotic, formulated using synthetic polymer technology to treat bacterial sepsis (blood poisoning) and other bacterial infections, including superbugs.
Filter
Announcement | T+2 Movement | Date |
---|---|---|
Day
3m
1yr
5yr
Current price
-
Open price
-
Day low-high
-
Price change
Percent change
Previous close
-
Volume
-
Turnover
-
Bid price
-
Ask price
-
Market cap
-
Shares outstanding
-
Year high
-
Year low
-
Year low-high
-
Earnings per share
-
Price/earnings ratio
-
Dividend yield
-
Dividend per share
-
Franking
-
Rank | Company | Market Cap |
---|---|---|
(03) 9028 2888
clients@freshequities.com
Level 19, 15 William St
Melbourne VIC 3000
Australia